STOCK TITAN

Equity awards for XOMA (XOMA) Chief Legal Officer include RSUs and PSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Montano Maricel Perea reported acquisition or exercise transactions in this Form 4 filing.

XOMA Royalty Corp reported that Chief Legal Officer Maricel Perea Montano received new equity awards. She was granted 26,289 restricted stock units payable in common stock, which vest in four equal annual installments starting on March 11, 2026, contingent on continued service.

She also received 40,444 performance stock units, each representing a right to one share of common stock. These performance units vest only if the common stock reaches a specified price per share and she remains in service, aligning a portion of her compensation with long-term share performance.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Montano Maricel Perea

(Last) (First) (Middle)
C/O XOMA ROYALTY CORPORATION
2200 POWELL STREET, SUITE 310

(Street)
EMERYVILLE CA 94608

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
XOMA Royalty Corp [ XOMA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/11/2026 A 26,289(1) A $0 38,423 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Stock Units (2) 03/11/2026 A 40,444 (2) (2) Common Stock 40,444 $0 40,444 D
Explanation of Responses:
1. Represents a grant of restricted stock units payable solely in common stock that will vest as to 25% on each of the first four anniversaries of March 11, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.
2. Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock. The PSUs vest upon the common stock achieving a specified price per share, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Remarks:
/s/ Maricel Montano 03/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did XOMA (XOMA) report for Maricel Perea Montano?

XOMA reported that Chief Legal Officer Maricel Perea Montano received two equity grants: 26,289 restricted stock units in common stock and 40,444 performance stock units. Both awards are contingent on future vesting conditions tied to continued service and, for the performance units, stock price targets.

How many restricted stock units did the XOMA Chief Legal Officer receive?

The Chief Legal Officer received 26,289 restricted stock units payable solely in XOMA common stock. These units vest in four equal installments of 25% each on the first four anniversaries of March 11, 2026, provided she continues serving the company through each vesting date.

What are the terms of the XOMA performance stock units granted on March 11, 2026?

XOMA granted 40,444 performance stock units on March 11, 2026. Each PSU represents a contingent right to receive one common share and vests only if the common stock reaches a specified price per share, subject to the executive’s continued service through the applicable vesting dates.

Did the XOMA insider buy or sell shares in the open market?

The filing shows no open-market buying or selling. Instead, the Chief Legal Officer acquired shares through equity compensation: a grant of restricted stock units and performance stock units, both awarded at no cash cost per share and subject to multi-year vesting and performance conditions.

What are the post-transaction holdings reported for XOMA common stock?

After the restricted stock unit grant, the filing reports that the Chief Legal Officer directly holds 38,423 shares of XOMA common stock. Separately, she holds 40,444 performance stock units, each representing a contingent right to receive one additional share upon satisfaction of specified vesting and price conditions.
XOMA Royalty Corporation

NASDAQ:XOMA

View XOMA Stock Overview

XOMA Rankings

XOMA Latest News

XOMA Latest SEC Filings

XOMA Stock Data

319.32M
12.16M
Biotechnology
Pharmaceutical Preparations
Link
United States
EMERYVILLE